| 7-TM receptor | seven-transmembrane receptor |
| ADAM10 | a disintegrin and metalloproteinase domain-containing protein 10 |
| ADAM17 | a disintegrin and metalloproteinase domain-containing protein 17, also known as tumor necrosis factor alpha converting enzyme (TACE) |
| AGEs | advanced glycation end products |
| Akt | protein kinase B |
| AP2 | adapter protein 2 |
| BAD protein | B-cell lymphoma 2-associated agonist of cell death protein |
| C/EBPβ | CCAAT/enhancer binding protein β–transcription factor |
| CD | chemokine domain |
| CD106 | cluster of differentiation 106, an adhesion molecule |
| c-MET | receptor tyrosine kinase |
| CTS | cathepsin S |
| CX3CL1 | chemokine C-X3-C motif ligand 1, also known as fractalkine (FKN) |
| CX3CR1 | ligand 1 (CX3CL1) receptor, also known as G-protein-coupled receptor 13 (GPR13), previously known as V28 |
| DAG | diacylglycerol |
| DCs | dendritic cells |
| DSCs | decidual stromal cells |
| ECL1–ECL3 | three extracellular loops within G-protein-coupled receptor (GPCR) |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| EGR1 | early growth response 1 protein |
| ELA | Elabela, |
| ELA-32 | Elabela-32, a mature, 32 amino acid containing, endogenous high affinity apelin receptor agonist |
| ELISA | enzyme-linked immunosorbent assay |
| eNOS | endothelial nitric oxide synthase |
| ER | endoplasmic reticulum |
| ERK1/2 | extracellular signal-regulated kinase ½ |
| FGR | fetal growth restriction (retardation) |
| FTDCs | first-trimester decidual cells |
| Gα, Gβ, Gγ | subunits of the heterotrimeric G proteins (G protein complex) |
| Gαi | activated Gα subunit of the G protein complex |
| GABA | gamma-aminobutyric acid |
| GABA-A receptor | gamma-aminobutyric acid receptor A |
| GABRP | gamma-aminobutyric acid receptor A π subunit |
| GEF | guanine nucleotide exchange factor |
| GDM | gestational diabetes mellitus |
| GDP | guanosine diphosphate |
| GH | growth hormone |
| GPCR | G-protein-coupled receptor |
| GRK | G-protein-coupled receptor kinase |
| GTP | guanosine triphosphate |
| hCG | human chorionic gonadotropin |
| HELLP syndrome | hemolysis, elevated liver enzymes and low platelets syndrome |
| HGF | hepatocyte growth factor, also known as scatter factor |
| HIF-1α | hypoxia-inducible factor 1 alpha |
| HLA-G | major histocompatibility complex (MHC) antigen, class I, G, also known as human leukocyte antigen G |
| HUVECs | human umbilical vein endothelial cells |
| ICL1–ICL3 | three intracellular loops within G-protein-coupled receptor (GPCR) |
| IDO1 | enzyme indoleamine 2,3-dioxygenase 1 |
| IFN-γ | interferon gamma |
| IL-1β, IL-6, IL-11 | interleukin-1β, -6, -11 respectively |
| ILT4 receptor | Ig-like transcript 4 inhibitory receptor |
| JAK | Janus kinase |
| LIF | leukemia inhibitory factor |
| Mφ | macrophage |
| M1 | proinflammatory polarized macrophages |
| M2 | anti-inflammatory polarized macrophages |
| MAP2K1 | mitogen-activated protein kinase kinase 1 encoding gene |
| MAP2K2 | mitogen-activated protein kinase kinase 2 encoding gene |
| MAPK | mitogen-activated protein kinase |
| MC | mast cells |
| MDSCs | myeloid-derived suppressor cells |
| MEK1 | mitogen-activated protein kinase kinase 1 |
| MEK2 | mitogen-activated protein kinase kinase 2 |
| MMP1, MMP-2, MMP12, MMP14, MMP15 | matrix metalloproteinases-1, -2, -12, -14 and -15, respectively |
| MT-MMPs | membrane-type matrix metalloproteinases |
| mTOR | mammalian target of rapamycin |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK cell | natural killer cell |
| p38 MAPKs | p38 mitogen-activated protein kinases |
| p70S6 kinase | ribosomal protein S6 kinase beta-1, also known as S6K1 |
| PBHSCs | peripheral blood-derived hematopoietic stem cells |
| PDK1 | phosphoinositide dependent kinase 1 |
| PE | preeclampsia |
| PI3K | phosphoinositide 3-kinase |
| PIP2 | phosphatidylinositol 4,5-bisphosphate |
| PIP3 | phosphatidylinositol (3,4,5)-trisphosphate |
| PKC | protein kinase C |
| PLC | phospholipase C |
| PRL | prolactin |
| RhoA | Ras homolog gene family member A |
| RIC8 | resistance to inhibitors of cholinesterase 8 homolog A |
| ROS | reactive oxygen species |
| RTKs | receptor tyrosine kinases |
| S6K1 | ribosomal protein S6 kinase beta-1, also known as p70S6 kinase |
| sCX3CL1 | soluble form of chemokine CX3CL1 (fractalkine) |
| SNARE | vesicle-associated v-soluble N-ethylmaleimide-sensitive factor attachment protein receptor |
| SP | signal peptide |
| STAT | signal transducer and activator of transcription protein |
| STX13 | protein syntaxin 13 |
| TACE | tumor necrosis factor alpha-converting enzyme, also known as a disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) |
| TLRs | toll-like receptors |
| TM1–TM7 | seven hydrophobic α-helical transmembrane segments or domains within a G protein-coupled receptor (GPCR) |
| TNF-α | tumor necrosis factor alpha |
| VAMP3 | vesicle-associated membrane protein 3 |
| VCAM-1 | vascular cell adhesion molecule 1 also known as vascular cell adhesion protein 1 |
| VCTs | villous cytotrophoblasts |
| VEGF-A | vascular endothelial growth factor isoform A |
| VEGFR-2 | vascular endothelial growth factor receptor type 2 |
| V/EVTI | vascular/extravascular tissue index |